share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC announcement ·  Feb 29 16:44
Summary by Moomoo AI
Moderna, Inc. (MRNA) has reported a transaction involving Chief Legal Officer Shannon Thyme Klinger. The transaction, dated 02/27/2024, involved the direct acquisition of Moderna's common stock. Following the transaction, Klinger holds a total of 7,912 shares of Moderna directly. The nature of the transaction indicates a vested interest in the company's performance by one of its top executives.
Moderna, Inc. (MRNA) has reported a transaction involving Chief Legal Officer Shannon Thyme Klinger. The transaction, dated 02/27/2024, involved the direct acquisition of Moderna's common stock. Following the transaction, Klinger holds a total of 7,912 shares of Moderna directly. The nature of the transaction indicates a vested interest in the company's performance by one of its top executives.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more